Pharmaceutical Technology, August 2010 Issue (PDF)

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-08-02-2010
Volume 34
Issue 8

Big Pharma?s Manufacturing Strategy: What is the Next Move?

External Link - article-819735.pdf

Articles in this issue
i1-683684-1408627530214.jpg
A Commendable Cleanroom Compendium
i1-683682-1408627535072.jpg
Bioburden Method Suitability for Cleaning and Sanitation Monitoring: How Far Do We Have to Go?
i4-683681-1408627538577.jpg
Adopting Serialization
i2-681732-1408629052896.gif
Manufacturing Failures Place GMP Compliance in Spotlight
i1-681720-1408629084425.jpg
An Ounce of Prevention
Statistical Considerations in Design Space Development (Part II of III)
Statistical Considerations in Design Space Development (Part II of III)
Turning a Blind Eye
FDA Perspectives: Common Deficiencies in Abbreviated New Drug Applications: Part 2: Description, Composition, and Excipients
FDA Perspectives: Common Deficiencies in Abbreviated New Drug Applications: Part 2: Description, Composition, and Excipients
Report from Asia
Report from Asia
Q&A with Jerry Jost
Q&A with Jerry Jost
i1-681728-1408629063403.jpg
Catalyst for Change
Big Pharma's Manufacturing Strategy: What is the Next Move?
Big Pharma's Manufacturing Strategy: What is the Next Move?
Engineering Processing Properties of Acetaminophen by Cosolvent Screening
Engineering Processing Properties of Acetaminophen by Cosolvent Screening
i1-681724-1408629073073.jpg
Project Managers Wanted
i3_t-681723-1408629075688.jpg
In the Spotlight August 2010
Recent Videos
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content
Teva Pharmaceuticals manufacturing site. Locally, Teva produces oral solid medicines and packaging. | Image Credit: © jetcityimage - stock.adobe.com

FDA Grants Fast Track Designation to Teva Celiac Disease Candidate

Patrick Lavery
May 30th 2025
Article

Teva’s investigational monoclonal antibody, TEV-53408, has been designed for use in adults with celiac disease, for which a strict and lifelong gluten-free diet is currently the only treatment.

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
May 30th 2025
Podcast

In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.

A lab technician in protective gear operates a tablet displaying a green checkmark in a high-tech pharmaceutical laboratory. | Image Credit: © greenbutterfly - stock.adobe.com

Companies Reveal Their Next Moves in Manufacturing

Patrick Lavery
May 29th 2025
Article

In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, sustainability, and the increasing utility of automation.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Site Logo

End-to-end regulatory CDMO solutions: development, manufacturing, and approval (May 2025)

Lonza
May 29th 2025
Article

Site Logo

Exploring the need for dose-flexible manufacturing

Lonza
May 29th 2025
Article